DiaMedica Therapeutics Inc logo

DiaMedica Therapeutics Inc

1
NEW
NAS:DMAC (USA)  
$ 4.37 +0.01 (+0.23%) 04:00 PM EST
At Loss
P/B:
3.50
Market Cap:
$ 186.80M
Enterprise V:
$ 134.42M
Volume:
46.32K
Avg Vol (2M):
55.93K
Trade In:
Volume:
46.32K
At Loss
Avg Vol (2M):
55.93K

Business Description

DiaMedica Therapeutics Inc logo
DiaMedica Therapeutics Inc
NAICS : 325412 SIC : 3741
ISIN : CA25253X1087
Description
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
Name Current Vs Industry Vs History
Cash-To-Debt 139.32
Equity-to-Asset 0.94
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 59.44
9-Day RSI 54.85
14-Day RSI 54.53
6-1 Month Momentum % 65.61
12-1 Month Momentum % 94.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.82
Quick Ratio 17.82
Cash Ratio 17.5

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26.5
Shareholder Yield % 0.03

Profitability Rank

Name Current Vs Industry Vs History
ROE % -37.38
ROA % -35.49
ROIC % -294.08
3-Year ROIIC % -1436.65
ROC (Joel Greenblatt) % -4564.44
ROCE % -41.79

Financials (Next Earnings Date:2024-11-13 Est.)

DMAC's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:DMAC

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

DiaMedica Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.53
Beta 0.83
Volatility % 38.27
14-Day RSI 54.53
14-Day ATR ($) 0.183163
20-Day SMA ($) 4.37975
12-1 Month Momentum % 94.88
52-Week Range ($) 2.12 - 4.95
Shares Outstanding (Mil) 42.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

DiaMedica Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

DiaMedica Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

DiaMedica Therapeutics Inc Frequently Asked Questions

What is DiaMedica Therapeutics Inc(DMAC)'s stock price today?
The current price of DMAC is $4.37. The 52 week high of DMAC is $4.95 and 52 week low is $2.12.
When is next earnings date of DiaMedica Therapeutics Inc(DMAC)?
The next earnings date of DiaMedica Therapeutics Inc(DMAC) is 2024-11-13 Est..
Does DiaMedica Therapeutics Inc(DMAC) pay dividends? If so, how much?
DiaMedica Therapeutics Inc(DMAC) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1